Rossari Biotech Limited announced that at the board meeting held on April 29, 2023, the company approved the final dividend of 25% (i.e. INR 0.50/- per share) on equity shares of the face value of INR 2/- each for the Financial Year ended March 31, 2023, subject To Approve the Shareholders at the forthcoming Annual General Meeting ("AGM") of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
691 INR | -0.50% | -0.48% | -13.49% |
01/05 | Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 | MT |
30/04 | Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.49% | 46Cr | |
+18.13% | 6.69TCr | |
+3.65% | 4.98TCr | |
+21.27% | 4.27TCr | |
+25.41% | 2.66TCr | |
+10.72% | 1.93TCr | |
-1.61% | 1.67TCr | |
+5.48% | 1.59TCr | |
-11.69% | 1.5TCr | |
-29.11% | 1.44TCr |
- Stock Market
- Equities
- ROSSARI Stock
- News Rossari Biotech Limited
- Rossari Biotech Limited Approves Final Dividend for the Financial Year Ended March 31, 2023